All News

A roundup of the latest news and updates for patients with acute myeloid leukemia from CURE®.

CURE® compiled a roundup of five recent reports patients with lymphoma may have missed.

Feeling overwhelmed and scared during cancer treatment is completely normal. Here are some tips to help patients conquer their fears each step of the way.

Arzerra will be available at no cost to patients via an oncology patient access program which will be facilitated through Patient Access Novartis Oncology.

Chadwick Boseman, known best for his role in “Black Panther,” has died after receiving a colon cancer diagnosis four years ago.

Eryaspase, a novel drug candidate, is being evaluated in patients with second-line metastatic pancreatic cancer and those with metastatic triple-negative breast cancer.

Nearly half (48%) of the patients reported experiencing significant fatigue following their surgery. Thirty-nine percent of the patients still reported significant fatigue one year following their surgery.

A former clinical trial designer at the National Cancer Institute offers patients with cancer advice on why they should consider joining clinical trials and provides insight into two common misconceptions about trials.

From Washington Football Team head coach Ron Rivera announcing he has cancer but plans to continue coaching this season, to ”Dancing With the Stars” judge Len Goodman revealing he had surgery to remove skin cancer from his face, here’s what’s happening in the cancer landscape this week.

In addition to improving progression-free survival, researchers have found single-agent Ninlaro (ixazomib) to be a tolerable option in patients with newly diagnosed multiple myeloma who have also already undergone an autologous stem cell transplant.

The novel next-generation ALK tyrosine kinase inhibitor improved survival, compared with Xalkori, in patients with ALK-positive non-small cell lung cancer, potentially representing a new option in the first-line setting.

This easy and healthy mango smoothie bowl recipe from the oncology dietitians at the John Theurer Cancer Center is sure to add some life to your breakfast when you get bored of your tried and true go-to’s.

I am not pining for the end of the pandemic, which makes me a bit of a weirdo among people I know, even though the end of the pandemic would be wonderful. I have been changed as a result of my cancer diagnosis, for it taught me that things can change at any moment.

The test was also approved as a companion diagnostic test to determine which select patients with metastatic castration-resistant prostate cancer could benefit from Rubraca, as well as for three frontline TKIs in patients with non-small cell lung cancer.

Here is a list of the recent trial initiations that occurred within the cancer space in August.

Often uncovered by accident, appendiceal cancers trigger few symptoms until they’re advanced and can be difficult to detect and treat.

I confronted my oncologist and dentist about the research I found. After doing their own research, they told me that cancer and treatment can weaken bone structure including teeth. I wish I had been told this earlier.

The Food and Drug Administration noted the trial design was acceptable for researchers to evaluate VERU-111 in in metastatic castration and novel androgen-blocking agent resistant prostate cancer.

The FDA has approved a generic form of the intravenous chemotherapy pemetrexed for use by itself in patients with locally advanced or metastatic non-squamous non-small cell lung cancer that has not progressed following four cycles of initial platinum-based chemotherapy.

The agent, in combination with the current standard of care, is being evaluated as a frontline treatment for patients with high-risk Denovo Genomic Marker 1 (DGM1)–positive DLBCL.

How one cancer thriver has found a small corner of control in an uncontrollable place.

“Through patients’ eyes, augmented intelligence may improve health care quality but should be implemented in a manner that preserves the integrity of the human physician-patient relationship,” the authors wrote.

At a median follow-up of 10 months, all patients who received Tafinlar plus Mekinist achieved an overall response rate of 51%.

On social media, CURE® recently asked its readers to share some tips for others for coping with roadblocks they might experience on their cancer journey. Here, we share some of their responses.

If you encounter mistreatment by any of your cancer providers, do not be afraid to expose them. If they are hurting you, they could be hurting others.

Dr. Jennifer L. Atlas notes that while these results could lead to a paradigm shift, surgery and radiation aren’t being eliminated as treatment options.

Life can be ridiculous, one survivor writes.

While it may seem beneficial to attach ourselves to the memories of our pre-cancer existence, it does little to help us focus on the here and now.

Anxiety, fear and panic may be some of the most difficult feelings to manage during cancer treatment. Here are some ways of dealing with these emotions to make you feel better.

Could paradigm shifts in cancer research help find a cure for cholangiocarcinoma? Experts discuss.